In-Vivo CRO Market Size, Trends, Analysis, and Outlook By Model (Rodent Based, Non-Rodent Based), By Modality (Small Molecules, Large Molecules), By Indication (Oncology, CNS Conditions, Diabetes, Obesity, Pain Management, Autoimmune/inflammation conditions, Others), By GLP Type (GLP Toxicology, Non GLP), by Region, Country, Segment, and Companies, 2024-2030
The global In-Vivo CRO market size is poised to register 8.9% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global In-Vivo CRO market across By Model (Rodent Based, Non-Rodent Based), By Modality (Small Molecules, Large Molecules), By Indication (Oncology, CNS Conditions, Diabetes, Obesity, Pain Management, Autoimmune/inflammation conditions, Others), By GLP Type (GLP Toxicology, Non GLP).
The In-Vivo Contract Research Organization (CRO) market is witnessing substantial growth due to the increasing outsourcing of preclinical research activities by pharmaceutical and biotechnology companies, rising demand for specialized expertise in in-vivo studies, and expanding drug development pipelines. In-Vivo CROs offer a wide range of services, including pharmacokinetic and toxicology studies, efficacy testing, and safety assessment in animal models, providing crucial data for regulatory submissions and decision-making processes. Factors such as the growing complexity of drug development, tightening regulatory requirements, and the need for cost-effective and time-efficient preclinical research solutions are driving the demand for In-Vivo CRO services. Additionally, advancements in research methodologies, the emergence of innovative animal models, and the adoption of novel technologies such as imaging modalities and molecular biology tools are further fueling market growth. Moreover, the increasing prevalence of chronic and infectious diseases, the rising demand for biologics and personalized medicine, and the expanding investments in R&D by pharmaceutical and biotechnology companies are expected to drive continued expansion in the In-Vivo CRO market in the foreseeable future.
In-Vivo CRO Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The In-Vivo CRO market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of In-Vivo CRO survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the In-Vivo CRO industry.
Key market trends defining the global In-Vivo CRO demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
In-Vivo CRO Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The In-Vivo CRO industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support In-Vivo CRO companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the In-Vivo CRO industry
Leading In-Vivo CRO companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 In-Vivo CRO companies.
In-Vivo CRO Market Study- Strategic Analysis Review
The In-Vivo CRO market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The In-Vivo CRO industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
In-Vivo CRO Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America In-Vivo CRO Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various In-Vivo CRO market segments. Similarly, Strong end-user demand is encouraging Canadian In-Vivo CRO companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico In-Vivo CRO market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe In-Vivo CRO Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European In-Vivo CRO industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European In-Vivo CRO market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific In-Vivo CRO Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for In-Vivo CRO in Asia Pacific. In particular, China, India, and South East Asian In-Vivo CRO markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America In-Vivo CRO Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa In-Vivo CRO Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East In-Vivo CRO market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for In-Vivo CRO.
In-Vivo CRO Market Company Profiles
The global In-Vivo CRO market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Biocytogen Boston Corp, Charles River Laboratories, Crown Bioscience, Evotec, GemPharmatech, Icon Plc, IQVIA Inc, Janvier Labs, Labcorp Drug Development, Parexel International Corp, PsychoGenics Inc, SMO Clinical Research (I) Pvt Ltd, Taconic Biosciences Inc
Recent In-Vivo CRO Market Developments
The global In-Vivo CRO market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
In-Vivo CRO Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Model Type
Rodent Based
-Rat Models
-Mice Models
-Others
Non-Rodent Based
By Modality
Small Molecules
Large Molecules
-Cell & Gene Therapy
-CAR T-Cell Therapies
-CAR-NK Cell Therapy
-TCR-T Cell Therapy
-Others
-RNA Therapy
-Others
By Indication
Oncology
-Blood cancer
-Solid tumor
-Syngeneic Model
-Patient Derived Xenograft
-Xenograft
-Others
CNS Conditions
-Epilepsy
-Parkinson's Disease
-Huntington's Disease
-Stroke
-Muscular Dystrophy
-Alzheimer’s Disease
-Traumatic Brain Injury
-Amyotrophic Lateral Sclerosis (ALS)
-Spinal Muscular Atrophy
-Muscle Regeneration
-Others
Diabetes
Obesity
Pain Management
-Chronic Pain
-Acute Pain
Autoimmune/inflammation conditions
-Rheumatoid Arthritis
-Multiple Sclerosis
-Osteoarthritis
-Irritable Bowel Syndrome
-Others
Others
By GLP Type
GLP Toxicology
Non GLP
Geographical Segmentation:
Biocytogen Boston Corp
Charles River Laboratories
Crown Bioscience
Evotec
GemPharmatech
Icon Plc
IQVIA Inc
Janvier Labs
Labcorp Drug Development
Parexel International Corp
PsychoGenics Inc
SMO Clinical Research (I) Pvt Ltd
Taconic Biosciences Inc
Formats Available: Excel, PDF, and PPT
The In-Vivo Contract Research Organization (CRO) market is witnessing substantial growth due to the increasing outsourcing of preclinical research activities by pharmaceutical and biotechnology companies, rising demand for specialized expertise in in-vivo studies, and expanding drug development pipelines. In-Vivo CROs offer a wide range of services, including pharmacokinetic and toxicology studies, efficacy testing, and safety assessment in animal models, providing crucial data for regulatory submissions and decision-making processes. Factors such as the growing complexity of drug development, tightening regulatory requirements, and the need for cost-effective and time-efficient preclinical research solutions are driving the demand for In-Vivo CRO services. Additionally, advancements in research methodologies, the emergence of innovative animal models, and the adoption of novel technologies such as imaging modalities and molecular biology tools are further fueling market growth. Moreover, the increasing prevalence of chronic and infectious diseases, the rising demand for biologics and personalized medicine, and the expanding investments in R&D by pharmaceutical and biotechnology companies are expected to drive continued expansion in the In-Vivo CRO market in the foreseeable future.
In-Vivo CRO Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The In-Vivo CRO market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of In-Vivo CRO survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the In-Vivo CRO industry.
Key market trends defining the global In-Vivo CRO demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
In-Vivo CRO Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The In-Vivo CRO industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support In-Vivo CRO companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the In-Vivo CRO industry
Leading In-Vivo CRO companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 In-Vivo CRO companies.
In-Vivo CRO Market Study- Strategic Analysis Review
The In-Vivo CRO market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The In-Vivo CRO industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
In-Vivo CRO Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America In-Vivo CRO Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various In-Vivo CRO market segments. Similarly, Strong end-user demand is encouraging Canadian In-Vivo CRO companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico In-Vivo CRO market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe In-Vivo CRO Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European In-Vivo CRO industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European In-Vivo CRO market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific In-Vivo CRO Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for In-Vivo CRO in Asia Pacific. In particular, China, India, and South East Asian In-Vivo CRO markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America In-Vivo CRO Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa In-Vivo CRO Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East In-Vivo CRO market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for In-Vivo CRO.
In-Vivo CRO Market Company Profiles
The global In-Vivo CRO market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Biocytogen Boston Corp, Charles River Laboratories, Crown Bioscience, Evotec, GemPharmatech, Icon Plc, IQVIA Inc, Janvier Labs, Labcorp Drug Development, Parexel International Corp, PsychoGenics Inc, SMO Clinical Research (I) Pvt Ltd, Taconic Biosciences Inc
Recent In-Vivo CRO Market Developments
The global In-Vivo CRO market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
In-Vivo CRO Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Model Type
Rodent Based
-Rat Models
-Mice Models
-Others
Non-Rodent Based
By Modality
Small Molecules
Large Molecules
-Cell & Gene Therapy
-CAR T-Cell Therapies
-CAR-NK Cell Therapy
-TCR-T Cell Therapy
-Others
-RNA Therapy
-Others
By Indication
Oncology
-Blood cancer
-Solid tumor
-Syngeneic Model
-Patient Derived Xenograft
-Xenograft
-Others
CNS Conditions
-Epilepsy
-Parkinson's Disease
-Huntington's Disease
-Stroke
-Muscular Dystrophy
-Alzheimer’s Disease
-Traumatic Brain Injury
-Amyotrophic Lateral Sclerosis (ALS)
-Spinal Muscular Atrophy
-Muscle Regeneration
-Others
Diabetes
Obesity
Pain Management
-Chronic Pain
-Acute Pain
Autoimmune/inflammation conditions
-Rheumatoid Arthritis
-Multiple Sclerosis
-Osteoarthritis
-Irritable Bowel Syndrome
-Others
Others
By GLP Type
GLP Toxicology
Non GLP
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Biocytogen Boston Corp
Charles River Laboratories
Crown Bioscience
Evotec
GemPharmatech
Icon Plc
IQVIA Inc
Janvier Labs
Labcorp Drug Development
Parexel International Corp
PsychoGenics Inc
SMO Clinical Research (I) Pvt Ltd
Taconic Biosciences Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 In-Vivo CRO Market Overview and Key Findings, 2024
1.2 In-Vivo CRO Market Size and Growth Outlook, 2021- 2030
1.3 In-Vivo CRO Market Growth Opportunities to 2030
1.4 Key In-Vivo CRO Market Trends and Challenges
1.4.1 In-Vivo CRO Market Drivers and Trends
1.4.2 In-Vivo CRO Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading In-Vivo CRO Companies
2. IN-VIVO CRO MARKET SIZE OUTLOOK TO 2030
2.1 In-Vivo CRO Market Size Outlook, USD Million, 2021- 2030
2.2 In-Vivo CRO Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. IN-VIVO CRO MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. IN-VIVO CRO MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Model Type
Rodent Based
-Rat Models
-Mice Models
-Others
Non-Rodent Based
By Modality
Small Molecules
Large Molecules
-Cell & Gene Therapy
-CAR T-Cell Therapies
-CAR-NK Cell Therapy
-TCR-T Cell Therapy
-Others
-RNA Therapy
-Others
By Indication
Oncology
-Blood cancer
-Solid tumor
-Syngeneic Model
-Patient Derived Xenograft
-Xenograft
-Others
CNS Conditions
-Epilepsy
-Parkinson's Disease
-Huntington's Disease
-Stroke
-Muscular Dystrophy
-Alzheimer’s Disease
-Traumatic Brain Injury
-Amyotrophic Lateral Sclerosis (ALS)
-Spinal Muscular Atrophy
-Muscle Regeneration
-Others
Diabetes
Obesity
Pain Management
-Chronic Pain
-Acute Pain
Autoimmune/inflammation conditions
-Rheumatoid Arthritis
-Multiple Sclerosis
-Osteoarthritis
-Irritable Bowel Syndrome
-Others
Others
By GLP Type
GLP Toxicology
Non GLP
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific In-Vivo CRO Market, 2025
5.2 Asia Pacific In-Vivo CRO Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific In-Vivo CRO Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe In-Vivo CRO Market, 2025
5.5 Europe In-Vivo CRO Market Size Outlook by Type, 2021- 2030
5.6 Europe In-Vivo CRO Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America In-Vivo CRO Market, 2025
5.8 North America In-Vivo CRO Market Size Outlook by Type, 2021- 2030
5.9 North America In-Vivo CRO Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America In-Vivo CRO Market, 2025
5.11 South America Pacific In-Vivo CRO Market Size Outlook by Type, 2021- 2030
5.12 South America In-Vivo CRO Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa In-Vivo CRO Market, 2025
5.14 Middle East Africa In-Vivo CRO Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa In-Vivo CRO Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US In-Vivo CRO Market Size Outlook and Revenue Growth Forecasts
6.2 US In-Vivo CRO Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada In-Vivo CRO Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico In-Vivo CRO Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany In-Vivo CRO Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France In-Vivo CRO Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK In-Vivo CRO Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain In-Vivo CRO Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy In-Vivo CRO Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe In-Vivo CRO Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China In-Vivo CRO Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India In-Vivo CRO Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan In-Vivo CRO Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea In-Vivo CRO Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia In-Vivo CRO Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia In-Vivo CRO Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific In-Vivo CRO Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil In-Vivo CRO Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina In-Vivo CRO Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America In-Vivo CRO Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East In-Vivo CRO Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa In-Vivo CRO Industry Drivers and Opportunities
7. IN-VIVO CRO MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. IN-VIVO CRO COMPANY PROFILES
8.1 Profiles of Leading In-Vivo CRO Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Biocytogen Boston Corp
Charles River Laboratories
Crown Bioscience
Evotec
GemPharmatech
Icon Plc
IQVIA Inc
Janvier Labs
Labcorp Drug Development
Parexel International Corp
PsychoGenics Inc
SMO Clinical Research (I) Pvt Ltd
Taconic Biosciences Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 In-Vivo CRO Market Overview and Key Findings, 2024
1.2 In-Vivo CRO Market Size and Growth Outlook, 2021- 2030
1.3 In-Vivo CRO Market Growth Opportunities to 2030
1.4 Key In-Vivo CRO Market Trends and Challenges
1.4.1 In-Vivo CRO Market Drivers and Trends
1.4.2 In-Vivo CRO Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading In-Vivo CRO Companies
2. IN-VIVO CRO MARKET SIZE OUTLOOK TO 2030
2.1 In-Vivo CRO Market Size Outlook, USD Million, 2021- 2030
2.2 In-Vivo CRO Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. IN-VIVO CRO MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. IN-VIVO CRO MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Model Type
Rodent Based
-Rat Models
-Mice Models
-Others
Non-Rodent Based
By Modality
Small Molecules
Large Molecules
-Cell & Gene Therapy
-CAR T-Cell Therapies
-CAR-NK Cell Therapy
-TCR-T Cell Therapy
-Others
-RNA Therapy
-Others
By Indication
Oncology
-Blood cancer
-Solid tumor
-Syngeneic Model
-Patient Derived Xenograft
-Xenograft
-Others
CNS Conditions
-Epilepsy
-Parkinson's Disease
-Huntington's Disease
-Stroke
-Muscular Dystrophy
-Alzheimer’s Disease
-Traumatic Brain Injury
-Amyotrophic Lateral Sclerosis (ALS)
-Spinal Muscular Atrophy
-Muscle Regeneration
-Others
Diabetes
Obesity
Pain Management
-Chronic Pain
-Acute Pain
Autoimmune/inflammation conditions
-Rheumatoid Arthritis
-Multiple Sclerosis
-Osteoarthritis
-Irritable Bowel Syndrome
-Others
Others
By GLP Type
GLP Toxicology
Non GLP
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific In-Vivo CRO Market, 2025
5.2 Asia Pacific In-Vivo CRO Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific In-Vivo CRO Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe In-Vivo CRO Market, 2025
5.5 Europe In-Vivo CRO Market Size Outlook by Type, 2021- 2030
5.6 Europe In-Vivo CRO Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America In-Vivo CRO Market, 2025
5.8 North America In-Vivo CRO Market Size Outlook by Type, 2021- 2030
5.9 North America In-Vivo CRO Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America In-Vivo CRO Market, 2025
5.11 South America Pacific In-Vivo CRO Market Size Outlook by Type, 2021- 2030
5.12 South America In-Vivo CRO Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa In-Vivo CRO Market, 2025
5.14 Middle East Africa In-Vivo CRO Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa In-Vivo CRO Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US In-Vivo CRO Market Size Outlook and Revenue Growth Forecasts
6.2 US In-Vivo CRO Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada In-Vivo CRO Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico In-Vivo CRO Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany In-Vivo CRO Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France In-Vivo CRO Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK In-Vivo CRO Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain In-Vivo CRO Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy In-Vivo CRO Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe In-Vivo CRO Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China In-Vivo CRO Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India In-Vivo CRO Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan In-Vivo CRO Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea In-Vivo CRO Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia In-Vivo CRO Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia In-Vivo CRO Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific In-Vivo CRO Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil In-Vivo CRO Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina In-Vivo CRO Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America In-Vivo CRO Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East In-Vivo CRO Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa In-Vivo CRO Industry Drivers and Opportunities
7. IN-VIVO CRO MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. IN-VIVO CRO COMPANY PROFILES
8.1 Profiles of Leading In-Vivo CRO Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Biocytogen Boston Corp
Charles River Laboratories
Crown Bioscience
Evotec
GemPharmatech
Icon Plc
IQVIA Inc
Janvier Labs
Labcorp Drug Development
Parexel International Corp
PsychoGenics Inc
SMO Clinical Research (I) Pvt Ltd
Taconic Biosciences Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
